scispace - formally typeset
K

Karthik Yamjala

Researcher at Jagadguru Sri Shivarathreeswara University

Publications -  17
Citations -  417

Karthik Yamjala is an academic researcher from Jagadguru Sri Shivarathreeswara University. The author has contributed to research in topics: Mass spectrometry & High-performance liquid chromatography. The author has an hindex of 6, co-authored 17 publications receiving 300 citations.

Papers
More filters
Journal ArticleDOI

Methods for the analysis of azo dyes employed in food industry--A review.

TL;DR: A comprehensive review of various analytical techniques used in the analysis of azo dyes employed in food industries of different parts of the world is presented.
Journal ArticleDOI

Current and emerging therapies in the management of diabetic foot ulcers.

TL;DR: The various drugs and therapies for the management of diabetic foot ulcers comprise antibiotics, neuropathic drugs, wound dressings, skin substitutes, growth factors and inflammatory modulators.
Journal ArticleDOI

Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles

TL;DR: The cytot toxicity, reactive oxygen species (ROS), determination revealed that the antitumor activity of DADS is enhanced with SLN compared to DADS-free drug, and apoptosis is the mechanism underlying the cytotoxicity.
Journal ArticleDOI

Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development.

TL;DR: The results of brain PTUPB, DA and its metabolites estimation shows a dose dependent increase inPTUPB concentration and a doses dependent prevention of ROT induced changes in DA andIts metabolites levels, indicating a significant neuroprotection activity of PTUPBs.
Journal ArticleDOI

Formulation and optimization of oxaliplatin immuno-nanoparticles using Box–Behnken design and cytotoxicity assessment for synergistic and receptor-mediated targeting in the treatment of colorectal cancer

TL;DR: The optimization of oxaliplatin solid lipid nanoparticles by microemulsion method optimizing it by Box–Behnken design and then covalently conjugated to TRAIL monoclonal antibody for targeting colorectal cancer cells confirmed the binding of the protein.